Skip to content

Study on Dedifferentiation Mechanism of Anaplastic Thyroid Carcinoma Based on Single Cell Sequencing Technology

Study on Dedifferentiation Mechanism of Anaplastic Thyroid Carcinoma Based on Single Cell Sequencing Technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000083
Enrollment
Unknown
Registered
2024-05-29
Start date
2023-12-29
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaplastic thyroid carcinoma

Interventions

ATC group:None

Sponsors

Wangjing Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: (1) Sex is not limited. The age is 18-95. (2) Meet the diagnostic criteria of western medicine for anaplastic thyroid cancer or differentiated thyroid cancer. TCM symptoms meet the diagnostic criteria of TCM syndromes. (3) The clinical data of each case are complete and true. (4) Not treated with any medication for the disease. (5) signed the informed consent form

Exclusion criteria

Exclusion criteria: (1) Patients with thyroid diseases other than thyroid cancer, including benign thyroid nodules, hyperthyroidism, thyroid thyroid adenoma; thyroid inflammatory disease patients, including Hashimoto's thyroiditis, subacute thyroiditis, Thyroid related eye diseases, etc. (2) Allergy or known allergy to certain drugs. (3) Patients with severe cardiovascular, cerebrovascular, liver, kidney and hematopoietic diseases, mania and schizophrenia requiring drug therapy. (4) Patients with other tumors. (5) Preparing for pregnancy, pregnant and lactating patients. (6) Participants in other clinical trials within the last three months. (7) History of neck radiation exposure.

Design outcomes

Primary

MeasureTime frame
Differential subgroups and differential genes;

Secondary

MeasureTime frame
Traditional Chinese medicine treatment scheme;

Countries

China

Contacts

Public ContactZhangPing

Wangjing Hospital of China Academy of Chinese Medical Sciences

zym_09@163.com13601382826

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026